Publications by authors named "Ahmad Gill"
Study Objective: Study the clinical outcomes associated with the number of concomitant vasopressors used in critically ill COVID-19 patients.
Design: A single-center retrospective cohort study was conducted on patients admitted with COVID-19 to the intensive care unit (ICU) between March and October 2020.
Setting: Rush University Medical Center, United States.
Article Synopsis
- A study was conducted comparing nonelective and elective transcatheter aortic valve replacement (TAVR) using the National Inpatient Sample database from 2016 to 2019, with a focus on in-hospital mortality rates.
- The results showed that patients undergoing nonelective TAVR had nearly double the odds (1.99 times) of in-hospital mortality compared to those undergoing elective TAVR, indicating a significant health risk for nonelective patients.
- The findings highlight that nonelective TAVR patients are particularly vulnerable and suggest a need for improved medical support and access to care in underserved areas as TAVR demand grows.
The rate of alcoholic hepatitis (AH) has risen in recent years. AH can cause as much as 40-50% mortality in severe cases. Successful abstinence has been the only therapy associated with long-term survival in patients with AH.
View Article and Find Full Text PDFStudy Objective: To compare the clinical outcomes in patients with congestive heart failure who are transferred to an acute care hospital from non-acute care centers with patients who are admitted as regular hospital admissions.
Design: This was a retrospective cohort study.
Setting: We utilized the National Inpatient Sample database from 2016 to 2018.
Introduction: Patients with pre-existing cardiovascular disease may carry a higher risk for mortality from COVID-19. This study examined the association between individuals with pre-existing cardiovascular disease admitted for COVID-19 and their clinical outcomes.
Methods: A retrospective cohort study was conducted on patients admitted with COVID-19 to Rush University System for Health (RUSH) to identify cardiovascular risk factors associated with increased mortality and major adverse cardiovascular events (MACE; a composite of cardiovascular death, stroke, myocardial injury, and heart failure exacerbation).
This randomized, controlled trial evaluated the effect of darbepoetin alfa on hospitalization days, transfusion requirements, hemoglobin levels, and fatigue in patients with anemia of cancer (AOC). Eligible patients were anemic (hemoglobin